Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Pharmacokinetic Evaluation of a New Naloxone Nasal Swab, Naloxone Nasal Spray, and Intramuscular Naloxone Injection in Healthy Volunteers
Phase 1
Completed
- Conditions
- Opioid Overdose
- Interventions
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- Pocket Naloxone Corp
- Target Recruit Count
- 76
- Registration Number
- NCT05363501
- Locations
- 🇨🇦
Altasciences, Québec, Quebec, Canada
News
NaxSwab OTC Naloxone Nasal Swab Demonstrates Successful Administration by Laypersons in Simulated Overdose Scenarios
A human factors validation study showed that both adults and adolescents could successfully administer NaxSwab™ OTC in a simulated opioid overdose emergency.